Progenika Biopharma SA creates a subsidiary in the UK

22-Jul-2005

Progenika Biopharma SA, an innovative Spanish company developing microarrays for genetic diagnosis, today announced the creation of a new subsidiary, Progenika Biopharma Ltd, to be based in the UK. The UK facility, which it is expected to come on line in Q1 2006, will initially process genetic diagnostic tests developed by the parent company in their headquarters and research facility on the outskirts of Bilbao, Spain.

Progenika Ltd will provide a diagnostic service based on the unique Sendagene(TM) platform for the diagnosis of genetically complex diseases. Dr Laureano Simon, company founder and CEO, underlined the enormous potential of the Sendagene(TM) technology for the early diagnosis of potentially debilitating conditions allowing doctors to treat and control important diseases suffered by their patients such as Familial Hypercholesterolaemia and Inflammatory Bowel Disease. The creation of Progenika Biopharma Ltd brings the possibility of individualized medicine one step closer to reality he said in a statement today.

Other news from the department manufacturing

Most read news

More news from our other portals

So close that even
molecules turn red...